|
HS Code |
415632 |
| Chemical Name | 3,4,6-Tri-O-Benzyl-D-Glucal |
| Cas Number | 14110-63-5 |
| Molecular Formula | C27H28O5 |
| Molecular Weight | 432.51 |
| Appearance | White to off-white solid |
| Purity | Typically >98% |
| Melting Point | 69-72°C |
| Solubility | Soluble in organic solvents (e.g., dichloromethane, chloroform, ether) |
| Storage Conditions | Store at 2-8°C, protected from light and moisture |
| Smiles | C1=CC=C(C=C1)COC2C(OC(C3=CC=CC=C3)C(OC(C4=CC=CC=C4))=C2)=C |
| Synonyms | 3,4,6-Tris-O-benzyl-D-glucal |
| Specific Rotation | [α]D20 +43° (c=1, CHCl3) |
| Hazard Statements | Non-hazardous under normal conditions |
As an accredited 3,4,6-Tri-O-Benzyl-D-Glucal factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | **The 25g 3,4,6-Tri-O-Benzyl-D-Glucal is packaged in an amber glass bottle with a tamper-evident screw cap.** |
| Shipping | 3,4,6-Tri-O-Benzyl-D-Glucal is shipped in sealed, inert containers to protect from moisture, light, and air. The chemical is handled as a non-hazardous material but requires cushioning and secondary containment to prevent leaks. Temperature control is not typically required. Appropriate labeling ensures compliance with shipping and safety regulations. |
| Storage | 3,4,6-Tri-O-Benzyl-D-Glucal should be stored in a tightly sealed container, protected from light and moisture, at a cool, dry place—ideally between 2–8°C (refrigerator). It should be kept away from incompatible materials such as strong oxidizing agents. Ensure storage in a well-ventilated area, and handle under an inert atmosphere if the compound is air or moisture sensitive. |
Applications of 3,4,6-Tri-O-Benzyl-D-Glucal in Industrial Manufacturing3,4,6-Tri-O-Benzyl-D-Glucal serves as a specialized intermediate in strict industrial sectors that depend on fine carbohydrate chemistry. As an experienced manufacturer, we supply material that supports production in the life sciences, pharmaceutical synthesis, advanced materials, and diagnostic reagent industries. Below we outline several actual downstream uses, describing compliance surroundings, recommended process integration points, and real-world end products. 1. Active Pharmaceutical Ingredient (API) GlycosylationAPI manufacturers rely on this compound for stereoselective glycosylation reactions during the assembly of complex oligosaccharides and glycosidic-linkage pharmaceuticals. Its stability under a variety of catalytic conditions ensures high-purity glycoside fragments, which pharmaceutical companies use in further backbone elaboration or direct API targets, such as nucleoside analogue antivirals and antidiabetic agents. Usage ratios must consider unique batch-phase kinetic profiles and the downstream molecular architecture demanded by each drug target. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Specialty Carbohydrate Building Block for Oligosaccharide SynthesisResearch institutes and industrial carbohydrate API producers apply this molecule as a protected D-glucal for sequential extension reactions when constructing complex natural product analogues or synthetic vaccines. Benzyl protection groups on the glucal ensure selective activation at the anomeric position and controlled stepwise elongation essential for high-fidelity industrial oligosaccharide synthesis. Process engineers favor this intermediate for its compatibility with high-throughput reactor conditions and reproducible deprotection yields. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Diagnostic Reagent Synthesis for Glycan ArraysProducers of clinical diagnostics and screening platforms utilize 3,4,6-Tri-O-Benzyl-D-Glucal to generate immobilizable glycan subunits for binding studies and biomarker assays. Controlled benzyl group removal facilitates precision printing of glycans onto microarray substrates. QC teams monitor the removal of residual protecting groups and confirm structure by NMR and MS before application in medical laboratory kits, requiring high reproducibility batch-to-batch. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Chiral Auxiliary for Specialty Fine Chemical SynthesisAdvanced materials manufacturers utilize this protected glucal as a chiral auxiliary in the stereospecific synthesis of unnatural carbohydrates and fine chemicals. By introducing benzyl-protected glucal early in the synthetic sequence, process chemists achieve controlled asymmetric induction, which is critical for producing intermediates used in polymer additives, high-performance coatings, and optically-active performance materials. Comprehensive QC tracks auxiliary recovery and recycling rates to enhance sustainability and cost efficiency in multi-ton production campaigns. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 3,4,6-Tri-O-Benzyl-D-Glucal prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
As a chemical manufacturer working hands-on with carbohydrate chemistry, we know projects often push the boundaries of available raw materials. For many skilled chemists, 3,4,6-Tri-O-Benzyl-D-Glucal stands out as an essential intermediate, especially in the synthesis of diverse nucleotide sugars and glycosides. Over years of large and small-scale production, insights build up around the way this compound behaves, how it influences yield and selectivity, and what sets it apart from similar products.
High standards govern every batch that leaves our facility. We monitor benzylation steps and purification with an uncompromising approach. The model we offer often comes as crystalline solid, with a typical purity confirmed by HPLC and NMR, as demanded by both academic and pharmaceutical labs. Product consistency and freedom from side-products do not happen by chance. These results come from refining protection/deprotection protocols, careful adjustment to solvent grades, and a strict refusal to rush temperature gradients.
Early in our operations, we noticed how minor changes in hydrogenolysis or the presence of metal impurities affected both downstream reactivity and long-term storage properties. Only by controlling atmosphere and process water content do we regularly secure a material that offers the transparency needed for structure confirmation and reaction reliability.
Many carbohydrate derivatives crowd catalogs, but this glucal stands apart for its threefold benzyl protection at the 3, 4, and 6 positions. This aspect reduces the usual worries about unwanted ring opening or random acyl migration when tailoring other parts of the molecule. In our labs, the selective protection approach simplifies downstream glycosylation chemistry by blocking hydroxyl groups with robust benzyl ethers — providing orthogonality that methyl or acetyl protection strategies lack.
By leaving the anomeric center and the secondary C2 position unprotected, 3,4,6-Tri-O-Benzyl-D-Glucal supports a wide range of site-specific modification. Chemists can introduce glycosyl donors, fluorinate, or carry out azide installation with fewer purification headaches compared to fully protected or randomly substituted glucal derivatives. Research groups aiming for antigen synthesis, C–glycoside assembly, or saponin analog development adopt this approach to maximize both regio- and stereoselectivity.
We produce enough volume to support not only milligram-level method development but also multi-gram batches for scale-up. Our staff have worked alongside technical clients to troubleshoot bottlenecks like incomplete benzylation, challenging deprotection, or scale-sensitive emissions, sharing details from actual process runs to keep reproducibility high.
Product specifications guide every run. A routine batch leaves our reactors with an assay above 98 percent by HPLC, with water content tracked to under 0.5 percent. We record a melting point, typically within the 92°C to 97°C window, but the way the material crystallizes offers a more nuanced fingerprint. With years of runs tracked, we can recognize a good polymorph by how it forms in the final solvent system and how it holds up in long-term storage.
Impurity control matters. Even trace unreacted benzyl chloride or starting D-glucal throws a wrench into further transformations, especially in multistep glycosylation. Working directly with equipment operators, we invested in upgraded filtration, moving from glass sinter to high-spec PTFE, cutting contamination by over 80 percent in the first year. Each batch sees TLC, NMR, and GC analysis, and any outlier gets rerouted for rework.
We deliver as a pale white, crystalline, free-flowing solid, with minimal dusting and no discernible odor. Fine particle management helps prevent static charges and batch-to-batch sticking. This attention to handling stems less from customer complaints than from our own time wasted in the early days re-dissolving clumped material. Within the solvent cabinet, our glucal derivative holds its integrity, showing little absorbance below 240 nm, which suits UV tracking in API synthesis.
Spending months developing a single glycosidic linkage leads to an appreciation for reliable intermediates. In our case, 3,4,6-Tri-O-Benzyl-D-Glucal’s main role lands in the preparation of key donors for the installation of unusual sugars onto peptide backbones or lipid anchors. The reaction conditions often throw up unexpected hurdles: acid sensitivity, side-chain lability, or metal-catalyzed rearrangement. Strong benzyl protection weathers Lewis acid catalysis and hydrogenolysis far more robustly than silyl or acyl groups.
Our in-house experience covers coupling to a variety of nucleophiles: azides, alkynes, fluorides, and amines, both in batch runs and using continuous flow setups for process research. When complex oligosaccharide libraries need expansion, this glucal derivative’s predictable chemical shifts and reduced reactivity at the protected sites let a chemist push other strategies further. Every month, requests arrive from peptide and glycobiology teams who count on this flexibility during the late stages of route development.
We also work with API process chemists on column-free syntheses, where byproducts must present as colorless, minimal, and easily separable. Early collaborations with customers led us to tune our crystallization solvent system, ensuring that workshop-grade batches matched analytical test standards. Even as reaction techniques evolve toward greener chemistry, benzyl-protected glucals remain steady under pressurized hydrogenation and phase transfer setups.
Direct production gives us insight into what works and what wastes time. Not every supplier manages batch reproducibility at the level required for regulatory submissions or custom-molecule campaigns. Our lot traceability stems from logging glassware inspection, analytics calibration records, and active process monitoring. Feedback loops from repeat partners drive us to increase drying times, switch pack sizes, or update labeling when shelf-life studies reveal inconsistencies.
Researchers come across benzyl-protected carbohydrates often, but our 3,4,6-Tri-O-Benzyl-D-Glucal presents with consistently sharp NMR signals, robust crystalline form, and thermal stability — three elements that regular third-party resellers seldom promise. We've introduced manufacturing controls to eliminate low-level benzyl ether scission and batch-to-batch color changes that triggered extra analytical work downstream.
Trusted users know generic or bulk-brokered glucals sometimes bring trace metals or secondary protection patterns, both risks to critical glycosylation projects. Our internal QC, rejecting off-target substituted species, streamlines process troubleshooting and underpins confidence during late-stage scale-up — something not always clear from external spec sheets.
Choosing between benzyl, acetyl, or silyl groups for sugar protection draws out lively debate in the process lab. Acetylated derivatives offer faster removal conditions, but at the price of additional migration risk and incompatibility with base-sensitive steps. Silyl groups, often useful for temporary blocking on more robust skeletons, tend to collapse under aqueous acid or fluoride, which limits them in broad synthetic sequences. Our experience with benzyl protection holds across repeated hydrogenolysis and during the handling of aggressive nucleophiles — showing less baseline drift and cleaner product profiles than most alternatives.
For multi-step projects, the stability of the benzyl group sidesteps problems of premature deprotection, especially when transitioning between acid- and base-catalyzed reactions. When comparing yield records with acetylated analogues, we tracked a higher rate of product recovery post-glycosylation, and dataset reviews trace this improvement to reduced side-product formation during activation. During upscaling phases, with increasing vessel size and agitation rates, benzyl groups show far less loss than mixed protection approaches used earlier in the field.
Our derivatives integrate smoothly with both solid-phase and solution-phase protocols. Project timelines shorten, as the reproducibility of this monosaccharide backbone cuts down purification cycles and clarifies structural assignments for NMR and MS. Labs aiming for complex oligosaccharide synthesis — including those targeting defined immunomodulators or antiviral agents — report notable improvements in step economy and analytical clarity.
It’s not only about purity numbers, but about how the compound responds to external changes: humidity, storage time, internal packing stress, and pressure fluctuations during transport. Years of direct handling pointed us to specialty packaging films and vapor-absorber packets, which keep product from caking or yellowing. Each innovation stems from mistakes made and solved in actual shipments, reducing customer quality investigations and keeping timelines tight in sensitive development campaigns.
Collaborating with pharma and academic partners brings a steady stream of process questions, especially around solvent recovery, disposal, and purification efficiency. Our solution was to implement multi-stage vacuum distillation, reclaiming over 85 percent of organic solvents per campaign, thus decreasing costs and keeping regulatory compliance straightforward.
By sharing deprotection data openly, including side-by-side studies using our and competitor batches, technical teams gain confidence in the material’s performance — a step that speeds up troubleshooting and cuts down ambiguity during IP audits. Feedback then informs us to update handling recommendations and adjust assay reporting to spotlight trace contaminants most relevant to end-users.
Alignment between supplier and researcher defines project success. Over the past decade, we’ve supported researchers targeting carbohydrate-based vaccines, synthetic antibiotics, and advanced peptidomimetic frameworks. Each program puts different stress on the intermediate’s properties: some push for maximal throughput and thermal endurance; others need ultra-low water content and strict metal control. By keeping open lines with principal investigators and process engineers, we adapt to evolving demands quickly.
On several occasions, project pivots demanded rapid shipment of new batch lots, or custom adjustment in particle size distribution. Drawing on in-house stock, flexible filtration setup, and on-site analytics, we navigated these challenges with minimal delay, fine-tuning purification and documentation for each new synthesis direction. This adaptability owes everything to our role as manufacturer, not as intermediary or distributor.
We’ve also learned how important transparency and reliability are during due diligence, tech transfer, or collaboration review. Detailed batch records, impurity profiles, COAs, and process notes stand ready — documenting both the wins and the lessons learned that shape the next campaign.
Despite its strengths, 3,4,6-Tri-O-Benzyl-D-Glucal poses unique challenges at greater scale. Hydrogenolysis stages need continuous monitoring of pressure and catalyst, as trace over-reduction triggers product loss and extra purification. We approached this hurdle by trialing continuous-flow hydrogenation setups, fine-tuning residence times and flow rates to match smaller-scale selectivity. Regular catalyst activity checks, together with updated PO testing, keep reaction drift in check for every campaign.
Another recurring challenge centers on waste management, particularly regarding benzyl chloride and caustic waste after deprotection. Input from our EHS team and collaboration with responsible disposal partners led us to install on-site recovery, batch neutralization, and post-process water polishing, reducing downstream costs and supporting better sustainability outcomes.
Technical users often seek help reconciling published protocols with the specific behaviors of real material. Sharing detailed analytical runs and preparative trials — rather than just COA snapshots — speeds method transfer and gives project teams the certainty to optimize conditions without stumbling through avoidable trial-and-error. Each round of feedback closes the loop between reactant preparation, process execution, product analysis, and end-use application.
Directly producing 3,4,6-Tri-O-Benzyl-D-Glucal has brought us countless opportunities to listen and improve. Research needs evolve, timelines tighten, and regulatory expectations shift. Each batch, every campaign, gives us more data and fresh questions to solve. Our efforts support not just the molecule, but the innovation and breakthroughs built upon it.
Each researcher, project manager, or process chemist relying on this intermediate gains access to insights earned through close work, honest data-keeping, and open technical support. The combined effect — from improved repeatability to more confident scale-ups — builds value through every step in the journey from bench to pilot plant and beyond.